Table 2.
Feature | Baseline | Post-treatment | Final Pathology |
---|---|---|---|
No visible disease | 0 (0%) | 4 (11%) | 2 (6%) |
Organ-confined disease | 6 (17%) | 21 (58%) | 23 (64%) |
Seminal vesical invasion | 10 (28%) | 6 (17%) | 8 (22%) |
Regional lymph node involvement | 10 (28%) | 7 (19%) | 5 (14%) |
Bladder/rectal invasion | 4 (11%) | 1 (3%) | 1 (3%) |